Two Sigma Investments’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.74M | Sell |
171,814
-3,312
| -2% | -$169K | 0.02% | 860 |
|
2025
Q1 | $7.89M | Buy |
175,126
+48,680
| +38% | +$2.19M | 0.02% | 838 |
|
2024
Q4 | $5.23M | Sell |
126,446
-101,027
| -44% | -$4.18M | 0.01% | 1030 |
|
2024
Q3 | $8.87M | Buy |
227,473
+63,933
| +39% | +$2.49M | 0.02% | 780 |
|
2024
Q2 | $5.59M | Buy |
163,540
+8,187
| +5% | +$280K | 0.01% | 904 |
|
2024
Q1 | $3.9M | Sell |
155,353
-40,775
| -21% | -$1.02M | 0.01% | 1057 |
|
2023
Q4 | $5.79M | Sell |
196,128
-132,656
| -40% | -$3.92M | 0.01% | 854 |
|
2023
Q3 | $10.4M | Buy |
328,784
+225,674
| +219% | +$7.13M | 0.03% | 563 |
|
2023
Q2 | $2.67M | Buy |
+103,110
| New | +$2.67M | 0.01% | 1193 |
|
2022
Q4 | – | Sell |
-47,748
| Closed | -$1M | – | 2910 |
|
2022
Q3 | $1M | Sell |
47,748
-73,544
| -61% | -$1.54M | ﹤0.01% | 1426 |
|
2022
Q2 | $2.36M | Sell |
121,292
-74,587
| -38% | -$1.45M | 0.01% | 1064 |
|
2022
Q1 | $4.31M | Buy |
195,879
+25,902
| +15% | +$570K | 0.01% | 959 |
|
2021
Q4 | $2.71M | Buy |
169,977
+14,702
| +9% | +$234K | 0.01% | 1188 |
|
2021
Q3 | $3.09M | Buy |
155,275
+61,360
| +65% | +$1.22M | 0.01% | 1135 |
|
2021
Q2 | $1.62M | Sell |
93,915
-2,105
| -2% | -$36.4K | ﹤0.01% | 1448 |
|
2021
Q1 | $1.9M | Buy |
96,020
+81,020
| +540% | +$1.61M | 0.01% | 1294 |
|
2020
Q4 | $262K | Sell |
15,000
-37,783
| -72% | -$660K | ﹤0.01% | 1766 |
|
2020
Q3 | $1.02M | Buy |
52,783
+7,990
| +18% | +$154K | ﹤0.01% | 1165 |
|
2020
Q2 | $872K | Buy |
+44,793
| New | +$872K | ﹤0.01% | 1209 |
|